I listened to the "WTF is Pharma?" episode with Rajeev Juneja of Mankind Pharma and GV Prasad of Dr. Reddy’s, and distilled the key take‑aways about India’s generic‑driven pharma ecosystem.
Dr. Reddy’s grew to a near‑USD 3 billion business under GV Prasad’s tenure.
These numbers illustrate why India remains the world’s volume‑driven generic pharmacy, yet its revenue share is a "barely a rounding error" compared with global pharma giants.